疫苗的共同临床决策：药师的工作并没有真正改变。
Shared clinical decision making on vaccines: Nothing has really changed for pharmacists.
出版信息
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e91-e94. doi: 10.1016/j.japh.2020.06.027. Epub 2020 Jul 27.
Abstract
Recently, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has begun utilizing a new recommendation known as "Shared Clinical Decision-Making." This recommendation from Centers for Disease Control and Prevention calls upon health care providers, including pharmacists, to have more engaged conversations with patients regarding their vaccine needs. This commentary is designed to provide pharmacists with clarifications on the intent behind this terminology, and dispel myths that have frequently been attributed to the category of recommendation. Pharmacists must continue to take action to immunize patients and not be confused by a new approach to recommendation terminology.
摘要
最近，疾病预防控制中心免疫实践咨询委员会开始采用一种新的推荐方法，称为“共享临床决策”。疾病预防控制中心的这项推荐要求包括药剂师在内的医疗保健提供者与患者就疫苗需求进行更深入的沟通。本文旨在为药剂师澄清该术语背后的意图，并消除经常归因于推荐类别的误解。药剂师必须继续采取行动为患者接种疫苗，不要被推荐术语的新方法所混淆。
相似文献
1
Shared clinical decision making on vaccines: Nothing has really changed for pharmacists.疫苗的共同临床决策：药师的工作并没有真正改变。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e91-e94. doi: 10.1016/j.japh.2020.06.027. Epub 2020 Jul 27.
2
Reflections on the Advisory Committee on Immunization Practices During the COVID-19 Pandemic.对 COVID-19 大流行期间免疫实践咨询委员会的反思。
Acad Pediatr. 2024 Sep-Oct;24(7):1038-1046. doi: 10.1016/j.acap.2024.06.019. Epub 2024 Jul 6.
3
Shared clinical decision-making on vaccines: out of sight, out of mind.疫苗的共同临床决策：视而不见，置若罔闻。
J Am Med Inform Assoc. 2021 Oct 12;28(11):2523-2525. doi: 10.1093/jamia/ocab147.
4
Strengthening vaccination policies in Latin America: an evidence-based approach.加强拉丁美洲的疫苗接种政策：循证方法。
Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25.
5
Shared decision-making for vaccines.疫苗的共同决策。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e55-e59. doi: 10.1016/j.japh.2020.05.010. Epub 2020 Jun 23.
6
7
Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC).美国疾病预防控制中心免疫实践咨询委员会（ACIP）制定基于证据的建议的方法。
Vaccine. 2011 Nov 15;29(49):9171-6. doi: 10.1016/j.vaccine.2011.08.005. Epub 2011 Aug 11.
8
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.《免疫实践咨询委员会关于 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗在年龄≥65 岁成人中使用的更新建议》。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075. doi: 10.15585/mmwr.mm6846a5.
9
Discrepancies Between US Food and Drug Administration Vaccine Licensure Indications and Advisory Committee on Immunization Practices Recommendations: Provider Knowledge and Attitudes.美国食品和药物管理局疫苗许可适应症与免疫实践咨询委员会建议之间的差异：提供者的知识和态度。
Clin Ther. 2018 Aug;40(8):1308-1319.e16. doi: 10.1016/j.clinthera.2018.07.004. Epub 2018 Aug 11.
10
The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).美国免疫实践咨询委员会（ACIP）的结构、作用和程序。
Vaccine. 2010 Apr 19;28 Suppl 1:A68-75. doi: 10.1016/j.vaccine.2010.02.037.
引用本文的文献
1
Do We Have a Common Understanding of How Vaccine Policy Affects Health Equity? Evaluating Variability in the Advisory Committee on Immunization Practices' Equity Assessment.我们对疫苗政策如何影响健康公平性是否有共同的理解？评估免疫实践咨询委员会公平性评估中的差异。
Vaccines (Basel). 2025 Feb 21;13(3):214. doi: 10.3390/vaccines13030214.
2
Healthcare Professionals' Knowledge, Attitudes, and Practices Regarding Respiratory Syncytial Virus Disease and Vaccination in Adults Aged 60 Years and Older.医疗保健专业人员对60岁及以上成年人呼吸道合胞病毒疾病及疫苗接种的知识、态度和实践
Infect Dis Ther. 2025 Apr;14(4):735-752. doi: 10.1007/s40121-025-01119-0. Epub 2025 Mar 14.
3
Perceived barriers and facilitators to HPV vaccination: Insights from focus groups with unvaccinated mid-adults in a U.S. medically underserved area.未接种 HPV 疫苗的美国医疗服务不足地区成年人焦点小组对 HPV 疫苗接种的认知障碍和促进因素。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2422681. doi: 10.1080/21645515.2024.2422681. Epub 2024 Nov 13.
4
The Impact of Social Determinants of Health on Meningococcal Vaccination Awareness, Delivery, and Coverage in Adolescents and Young Adults in the United States: A Systematic Review.健康的社会决定因素对美国青少年和青年脑膜炎球菌疫苗接种意识、接种实施及覆盖率的影响：一项系统综述
Vaccines (Basel). 2023 Jan 24;11(2):256. doi: 10.3390/vaccines11020256.
5
Physician survey regarding updated PCV13 vaccine recommendations for adults ≥65 years.针对≥65 岁成年人的更新 PCV13 疫苗推荐意见的医师调查。
J Am Geriatr Soc. 2021 Sep;69(9):2612-2618. doi: 10.1111/jgs.17274. Epub 2021 May 14.
本文引用的文献
1
Optimizing the immunization activities of community chain pharmacists: Insights from a national survey.优化社区连锁药剂师的免疫接种活动：全国调查的见解。
J Am Pharm Assoc (2003). 2020 Sep-Oct;60(5):686-693. doi: 10.1016/j.japh.2020.02.009. Epub 2020 Mar 17.
2
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices.《免疫实践咨询委员会关于 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗在年龄≥65 岁成人中使用的更新建议》。
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075. doi: 10.15585/mmwr.mm6846a5.
3
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.美国乙型肝炎病毒感染预防：免疫实践咨询委员会的建议。
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. doi: 10.15585/mmwr.rr6701a1.
4
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant.免疫实践咨询委员会关于使用含新型佐剂的乙型肝炎疫苗的建议。
MMWR Morb Mortal Wkly Rep. 2018 Apr 20;67(15):455-458. doi: 10.15585/mmwr.mm6715a5.
5
Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine - Advisory Committee on Immunization Practices, 2016.B群脑膜炎球菌结合疫苗（MenB-FHbp）使用的更新建议 - 免疫实践咨询委员会，2016年
MMWR Morb Mortal Wkly Rep. 2017 May 19;66(19):509-513. doi: 10.15585/mmwr.mm6619a6.
6
Coverage of Certain Preventive Services Under the Affordable Care Act. Final rules.《平价医疗法案》规定的某些预防服务覆盖范围。最终规则。
Fed Regist. 2015 Jul 14;80(134):41317-47.
7
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).《65 岁及以上成人中使用 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗：免疫实践咨询委员会（ACIP）的建议》。
MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5.
Zotero 插件